A Phase I Clinical Trial of Ad5/3-Δ24, a Novel Serotype-Chimeric, Infectivity-Enhanced, Conditionally-Replicative Adenovirus (CRAd), in Patients with Recurrent Ovarian Cancer

OBJECTIVE: The conditionally replicative adenovirus Ad5/3-Δ24 has a type-3 knob incorporated into the type-5 fiber that facilitates enhanced ovarian cancer infectivity. Preclinical studies have shown that Ad5/3-Δ24 achieves significant oncolysis and antitumor activity in ovarian cancer models. The p...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Kim, Kenneth H., Dmitriev, Igor P., Saddekni, Souheil, Kashentseva, Elena A., Harris, Raymond D., Aurigemma, Rosemarie, Bae, Sejong, Singh, Karan P., Siegal, Gene P., Curiel, David T., Alvarez, Ronald D.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2013
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748258/
https://ncbi.nlm.nih.gov/pubmed/23756180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.06.003
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन